Ixazomib Maintenance Study in Patients With AL Amyloidosis
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works
to control the disease. Through this study, the investigators hope to learn more about ways
to prevent or delay relapse of AL Amyloidosis.
Phase:
Phase 2
Details
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborators:
Tufts Medical Center Vanderbilt University Medical Center